Genetic polymorphisms and the fate of the transplanted organ (Q37218129)

19 August 2017

1 reference

title

Genetic polymorphisms and the fate of the transplanted organ (English)

1 reference

19 August 2017

3

Barbara T Murphy

1 reference

19 August 2017

Bernd Krüger

1

1 reference

19 August 2017

Bernd Schröppel

series ordinal

2

1 reference

19 August 2017

publication date

1 April 2008

1 reference

19 August 2017

published in

Transplantation Reviews

1 reference

19 August 2017

volume

22

1 reference

19 August 2017

issue

2

1 reference

19 August 2017

page(s)

131-140

1 reference

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Chronic renal allograft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Five preventable causes of kidney graft loss in the 1990s: a single-center analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

The many roles of chemokines and chemokine receptors in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Cytokine gene polymorphisms predict acute graft rejection following renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

The impact of recipient cytokine genotype on acute rejection after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Cooperative influence of the interleukin-6 promoter polymorphisms -597, -572 and -174 on long-term kidney allograft survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

The interleukin-6 -174promoter polymorphism is associated with long-term kidney allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Immune response gene polymorphisms in renal transplant recipients

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Impaired kidney graft survival is associated with the TNF-alpha genotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Cytokine gene polymorphism and heart transplant rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Interleukin-10 and the interleukin-10 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Posttransplantation diabetes: a systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

CC chemokine receptor 5 and renal-transplant survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CCR5 in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Adhesion molecule polymorphisms in chronic renal allograft failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Identification of ICAM-1 polymorphism that is associated with protection from transplant associated vasculopathy after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Novel immunosuppression: small molecules and biologics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

CTLA4 gene polymorphism and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Polymorphsims of CTLA-4 exon 1 +49, CTLA-4 promoter -318 and Fas promoter -670 in spondyloarthropathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

The Impact of Costimulatory Molecule Gene Polymorphisms on Clinical Outcomes in Liver Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Genetic variability and transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Recipient ctla-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Cooperation of Toll-like receptor signals in innate immune defence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Innate immunity and organ transplantation: the potential role of toll-like receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Toll like receptors and acute allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Impact of NOD2/CARD15 haplotypes on the outcome after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Innate and adaptive immunity in the pathogenesis of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Predominant role for C5b-9 in renal ischemia/reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Decay-accelerating factor modulates induction of T cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Influence of donor C3 allotype on late renal-transplantation outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

The role of mannose-binding lectin in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Association between mannose-binding lectin levels and graft survival in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Hypertension in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism and IgA nephropathy: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients: a single-center analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Donor ACE gene polymorphism: a genetic risk factor for accelerated coronary sclerosis following cardiac transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

ACE-gene polymorphism is associated with the development of allograft vascular disease in heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

ACE gene polymorphism and long-term renal graft function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Angiotensin-converting-enzyme insertion/deletion genotype and long-term renal allograft survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Recipient RAS gene variants and renal allograft function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Structural analysis and evaluation of the aldosterone synthase gene in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Factor V Leiden mutation: potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Donor factor V leiden mutation and vascular thrombosis following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Hyperhomocysteinemia: an independent risk factor for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

First-pass metabolism of cyclosporin by the gut

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

A family of drug transporters: the multidrug resistance-associated proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Identification of functionally variant MDR1 alleles among European Americans and African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Association of CYP3A4 genotype with treatment-related leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Finding genes that underlie complex traits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Problems of reporting genetic associations with complex outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Proposed guidelines for papers describing DNA polymorphism-disease associations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Ethnicity greatly influences cytokine gene polymorphism distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.002

10.1016/J.TRRE.2007.12.002

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference